Funded Tech Companies
Sparrow Pharmaceuticals
Wondering who backed Sparrow Pharmaceuticals? OrbiMed, U.S. Venture Partners and Forbion Capital Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Sparrow Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
920 SW 6th Ave. 1200
Portland, OR 97204
USA
Portland, OR 97204
USA
Phone
Website
Email Address
Company Background Information
Overview
Sparrow Pharmaceuticals is an emerging clinical-stage biopharmaceutical company developing novel, targeted therapies for disorders of corticosteroid excess. We are developing novel therapies to address the key limitations of treatments for endogenous Cushing's syndrome (Cushing's), autonomous cortisol secretion (ACS), and polymyalgia rheumatica (PMR).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/24/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Jacks
Chief Scientific Officer
David Katz
Vice President
Jeffrey Drajesk
Company Investors
- OrbiMed (Klaus Veitinger)
- U.S. Venture Partners
- Forbion Capital Partners
- RA Capital Management
- RiverVest Venture Partners
- Matter
Browse more funded tech companies:
Sparrow Biologic | Sparrow Quantum
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs